Fasting-Induced HbA1c Reduction as a Tumor-Suppressive Strategy: Depriving the Tumor Microenvironment of the "Sugar-Iron Bomb" — A Mechanistic Hypothesis and Follow-up to Abuamra (2026)
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Veröffentlicht: |
Zenodo
2026
|
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901712715907072 |
|---|---|
| author | Abuamra, Mohammed Fuad Yousef |
| author_facet | Abuamra, Mohammed Fuad Yousef |
| contents | <p>The recently proposed "Sugar-Iron Bomb" hypothesis (Abuamra, 2026) posits that glycosylated hemoglobin (HbA1c)-laden red blood cells (RBCs) act as localized detonators of carcinogenesis upon hemolysis in peripheral tissues, releasing labile heme-iron that catalyzes the Fenton reaction and produces mutagenic hydroxyl radicals (•OH). Building on this framework, the present paper proposes a testable therapeutic corollary: that intentional, sustained reduction of HbA1c — whether through intermittent fasting, fasting-mimicking diets, or pharmacological intervention — can deprive the tumor microenvironment (TME) of these "sugar-iron bombs," thereby reducing de novo mutagenic events, destabilizing the TME, and slowing tumor progression. This hypothesis offers a novel mechanistic explanation for the documented but poorly understood anti-cancer effects of fasting and glycemic control. It posits that therapeutic HbA1c reduction simultaneously starves the TME of glucose and, critically, of the focal iron bursts required for sustained genomic instability and clonal evolution. The paper outlines the biochemical rationale, supporting clinical and epidemiological clues, and a detailed experimental design for validation.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19902054 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Fasting-Induced HbA1c Reduction as a Tumor-Suppressive Strategy: Depriving the Tumor Microenvironment of the "Sugar-Iron Bomb" — A Mechanistic Hypothesis and Follow-up to Abuamra (2026) Abuamra, Mohammed Fuad Yousef <p>The recently proposed "Sugar-Iron Bomb" hypothesis (Abuamra, 2026) posits that glycosylated hemoglobin (HbA1c)-laden red blood cells (RBCs) act as localized detonators of carcinogenesis upon hemolysis in peripheral tissues, releasing labile heme-iron that catalyzes the Fenton reaction and produces mutagenic hydroxyl radicals (•OH). Building on this framework, the present paper proposes a testable therapeutic corollary: that intentional, sustained reduction of HbA1c — whether through intermittent fasting, fasting-mimicking diets, or pharmacological intervention — can deprive the tumor microenvironment (TME) of these "sugar-iron bombs," thereby reducing de novo mutagenic events, destabilizing the TME, and slowing tumor progression. This hypothesis offers a novel mechanistic explanation for the documented but poorly understood anti-cancer effects of fasting and glycemic control. It posits that therapeutic HbA1c reduction simultaneously starves the TME of glucose and, critically, of the focal iron bursts required for sustained genomic instability and clonal evolution. The paper outlines the biochemical rationale, supporting clinical and epidemiological clues, and a detailed experimental design for validation.</p> |
| title | Fasting-Induced HbA1c Reduction as a Tumor-Suppressive Strategy: Depriving the Tumor Microenvironment of the "Sugar-Iron Bomb" — A Mechanistic Hypothesis and Follow-up to Abuamra (2026) |
| url | https://doi.org/10.5281/zenodo.19902054 |